West Pharmaceutical Services Inc
West Pharmaceutical Services Inc/ US9553061055 /
WST
|
4/19/2021 5:36:14 PM
|
Chg.
+0.04
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
314.17USD
|
+0.01%
|
7,163
Turnover: 2.26 mill. |
-Bid Size: - |
-Ask Size: - |
23.26 bill.USD |
0.20% |
95.98 |
Fundamentals
| |
FY 2019 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
3.27 USD |
16.79% |
| EPS Diluted: |
3.21 USD |
17.15% |
| Revenues per Share: |
24.86 USD |
6.99% |
| Book Value per Share: |
21.26 USD |
12.52% |
| Cash Flow per Share: |
4.96 USD |
27.06% |
| Dividend per Share: |
0.62 USD |
6.90% |
| Total |
in mill. |
|
| Revenues: |
1,839.90 USD |
7.13% |
| Net Income: |
241.70 USD |
16.82% |
| Operating Cash Flow: |
367.20 USD |
- |
| Cash and Cash Equivalents: |
439.10 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
95.98 |
45.97 |
| P/S Ratio: |
12.62 |
6.05 |
| P/BV ratio: |
14.76 |
7.07 |
| P/CF Ratio: |
63.25 |
30.30 |
| PEG: |
5.72 |
2.74 |
| Earnings Yield: |
1.04% |
2.18% |
| Dividend Yield: |
0.20% |
0.41% |
| Market Capitalization |
|
| Market Capitalization: |
23.26 bill. USD |
11.12 bill. USD |
| Free Float Market Cap.: |
14.81 bill. USD |
7.09 bill. USD |
| Market Cap. / Employee: |
2.83 mill. USD |
1.36 mill. USD |
| Shares Outstanding: |
74.1 mill. |
|
Profitability
| Gross Profit Margin: |
32.92% |
| EBIT Margin: |
16.12% |
| Net Profit Margin: |
13.14% |
| Return on Equity: |
15.36% |
| Return on Assets: |
10.32% |
Financial Strength
| Liquidity I / Cash Ratio: |
128.54% |
| Liquidity II / Quick Ratio: |
222.01% |
| Liquidity III / Current Ratio: |
309.92% |
| Debt / Equity Ratio: |
48.83% |
| Dynam. Debt / Equity Ratio: |
209.20% |
Efficiency
| Employees: |
8,200 |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
224,378.05 USD |
| Net Income / Employee: |
29,475.61 USD |
| Total Assets / Employee: |
285,536.59 USD |
| * Fiscal Year End: |
12/31/2019 |
| Accounting Standard: |
US GAAP |